Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Avidity Biosciences, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $107 Billion
- Q1 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 6,135 shares of RNA stock, worth $226,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,135
Previous 5,621
9.14%
Holding current value
$226,258
Previous $163,000
11.04%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RNA
# of Institutions
243Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$421 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$418 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$357 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$341 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$323 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.92B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...